Using Neural Stem Cell Delivered Oncolytic Viruses for the Treatment of Glioma & Ovarian Cancer
Time: 4:00 pm
day: Conference Day One
Details:
- Discussing the unique approach of using tumor-tropic NSCs as delivery vehicles of oncolytic viruses
- Discuss current multi-dose, multi-site glioma clinical trial and planned 2026 ovarian cancer clinical trials using this approach
- Manufacturing overview
